Tobias Holscher
Overview
Explore the profile of Tobias Holscher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
592
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Marinescu I, Spohn S, Kiefer S, Bronsert P, Ceci L, Holzschuh J, et al.
Front Oncol
. 2022 Aug;
12:880042.
PMID: 35912219
Introduction: Accurate detection and segmentation of the intraprostatic gross tumor volume (GTV) is pivotal for radiotherapy (RT) in primary prostate cancer (PCa) since it influences focal therapy target volumes and...
12.
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
Muller A, Aebersold D, Albrecht C, Bohmer D, Flentje M, Ganswindt U, et al.
Strahlenther Onkol
. 2022 Jun;
198(8):683-689.
PMID: 35704054
Purpose: The DEGRO Expert Commission on Prostate Cancer has revised the indication for radiation therapy of the primary prostate tumor in patients with synchronous distant metastases with low metastatic burden....
13.
Holscher T, Baumann M, Kotzerke J, Zophel K, Paulsen F, Muller A, et al.
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565207
Progression of prostate-specific antigen (PSA) values after curative treatment of prostate cancer patients is common. Prostate-specific membrane antigen (PSMA-) PET imaging can identify patients with metachronous oligometastatic disease even at...
14.
Froehner M, Coressel Y, Koch R, Borkowetz A, Thomas C, Wirth M, et al.
World J Urol
. 2022 Mar;
40(6):1463-1468.
PMID: 35303155
Purpose: To investigate acceptance and efficacy of recommended adjuvant radiotherapy in patients with positive lymph nodes at radical prostatectomy. Methods: Among 495 patients with positive lymph nodes who consecutively underwent...
15.
Beck M, Sassowsky M, Schar S, Mathier E, Halter M, Zwahlen D, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jan;
113(1):80-91.
PMID: 34990777
Purpose: To evaluate the results of the radiation therapy (RT) quality assurance (QA) program of the phase 3 randomized SAKK 09/10 trial in patients with biochemically recurrent prostate cancer after...
16.
Holscher T, Baumann M, Kotzerke J, Zophel K, Paulsen F, Muller A, et al.
Eur Urol Oncol
. 2021 Nov;
5(1):44-51.
PMID: 34785189
Background: Local ablative radiotherapy (aRT) of oligometastatic prostate cancer (PCa) is very promising and has become a focus of current clinical research. Objective: We hypothesize that aRT is safe and...
17.
Hoberuck S, Lock S, Borkowetz A, Sommer U, Winzer R, Zophel K, et al.
EJNMMI Res
. 2021 Oct;
11(1):109.
PMID: 34665337
Background: The analysis aimed to compare the radiotracers [Ga]-Ga-PSMA-11 and [F]-F-PSMA-1007 intraindividually in terms of malignant lesions, mi(molecular-imaging)TNM staging and presumable unspecific lesions retrospectively as used in routine clinical practice....
18.
Shelan M, Aebersold D, Albrecht C, Bohmer D, Flentje M, Ganswindt U, et al.
Strahlenther Onkol
. 2021 Aug;
197(11):993-1000.
PMID: 34463814
Purpose: Various randomized phase III clinical trials have compared moderately hypofractionated to normofractionated radiotherapy (RT). These modalities showed similar effectiveness without major differences in toxicity. This project was conducted by...
19.
Spohn S, Bettermann A, Bamberg F, Benndorf M, Mix M, Nicolay N, et al.
Theranostics
. 2021 Aug;
11(16):8027-8042.
PMID: 34335978
Prostate cancer (PCa) is one of the most frequently diagnosed malignancies of men in the world. Due to a variety of treatment options in different risk groups, proper diagnostic and...
20.
Mukha A, Kahya U, Linge A, Chen O, Lock S, Lukiyanchuk V, et al.
Theranostics
. 2021 Aug;
11(16):7844-7868.
PMID: 34335968
Radiotherapy is one of the curative treatment options for localized prostate cancer (PCa). The curative potential of radiotherapy is mediated by irradiation-induced oxidative stress and DNA damage in tumor cells....